Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
US-12186433-B2 · Jan 7, 2025 · US
This page is not indexed by search engines while we improve data quality.
Centre Hospitalier Univ Dangers Cedex France — Human Necessities
Centre Hospitalier Univ Dangers Cedex France holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Centre Hospitalier Univ Dangers Cedex France |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 1 |
| First year | 2025 |
| Last year | 2025 |
Representative patents
Notable publications linking Centre Hospitalier Univ Dangers Cedex France to Human Necessities.
Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
US-12186433-B2 · Jan 7, 2025 · US
Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
US-12186433-B2 · Jan 7, 2025 · US
Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
US-12186433-B2 · Jan 7, 2025 · US
Recent filings
Latest patents from Centre Hospitalier Univ Dangers Cedex France in Human Necessities.
Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
US-12186433-B2 · Jan 7, 2025 · US
Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
US-12186433-B2 · Jan 7, 2025 · US
Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
US-12186433-B2 · Jan 7, 2025 · US
Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
US-12186433-B2 · Jan 7, 2025 · US
Related pages
Navigate to parent entity pages.